Medical-device maker Masimo may opt for a joint venture as it looks to split off its consumer business. The company, which ...

Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could squeeze future profitability. During the fourth quarter, Masimo earned an ...

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives. Apple and Masimo have ...

Masimo is up 10.4% since the beginning of the year, and at $186.09 per share, has set a new 52-week high. Investors who bought $1,000 worth of Masimo’s shares 5 years ago would now be looking at ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 earnings beat. The company is moving quickly with ...

Piper Sandler analyst Jason Bednar raised the firm’s price target on Masimo (MASI) to $215 from $210 and keeps an Overweight rating on the shares. The firm notes the company announced Q4 revenue ...

It was hard to miss CoCo Vandeweghe’s commercial for the Masimo MightySat during Indian Wells. The 30-second ad for the newly released fingertip pulse oximeter played on nearly every changeover.